Cord Blood America, Inc. (CBAI) [Rocket]

Overview

Cord Blood America, Inc. (CBAI)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
02/16/2022	REVOKED	Form REVOKED - Commission order revoking Exchange Act registration [Section 12(j)]:
09/23/2020	8-K	Quarterly results
08/04/2020	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
08/04/2020	S-8 POS	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
Revenues	-1.3	-7.8	0.0	0.0	5.2	4.3	3.8	6.0
Revenue growth	-83.5%			-100.0%	20.7%	13.3%	-36.2%	18.1%
Cost of goods sold	0.0	0.0	0.0	0.0	1.9	0.0	0.0	1.8
Gross profit	-1.3	-7.8	0.0	0.0	3.4	4.3	3.8	4.2
Gross margin	100.0%	100.0%			64.3%	100.0%	100.0%	70.1%
Selling, general and administrative	-0.6	-3.9	1.7	2.1	3.0	3.1	2.9	5.6
EBITA	-0.6	-3.9	-1.4	-1.8	0.4	0.6	-0.2	-1.2
EBITA margin	50.0%	50.0%			6.9%	13.9%	-4.8%	-20.8%
Amortization of intangibles			0.3	0.3
EBIT	-0.6	-3.9	-1.7	-2.1	0.4	0.6	-0.2	-1.2
EBIT margin	50.0%	50.0%			6.9%	13.9%	-4.8%	-20.8%
Pre-tax income	-0.4	15.3	0.4	-1.9	0.4	0.2	-3.0	-2.4
Income taxes	-0.1	0.7	0.0	0.0	0.0	0.0	0.0	-1.3
Tax rate	21.4%	4.7%	0.0%	0.0%	0.0%	0.0%	0.0%	54.0%
Earnings from continuing ops	-0.3	-3.1	-1.6	-1.9	0.4	-0.3	-1.5	0.7
Earnings from discontinued ops	0.3	16.2	2.0	2.0
Net income	0.0	13.2	0.4	0.1	0.4	-0.3	-1.5	0.7
Net margin	2.9%	-169.9%			8.4%	-7.8%	-40.2%	11.3%

Diluted EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Shares outstanding (diluted)	1,272.1	1,272.1	1,272.1	1,272.1	1,272.1	895.1	747.1	252.7

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.